PATH | VRL
Menu

A Cost Comparison of Introducing and Delivering Pneumococcal, Rotavirus and Human Papillomavirus Vaccines in Rwanda

This article, published in Vaccine, reports on a cost comparison of introducing multiple vaccines in a single country and then assessing the financial and economic impact at the time and implications for the future. The objective of the analysis was to understand the introduction and delivery cost per dose or per child of three new vaccines—pneumococcal conjugate, rotavirus, and human papillomavirus (HPV)—in Rwanda to inform domestic and external financial resource mobilization. The results indicate that service delivery strategies have an important influence on the costs of introducing new vaccines, and costs per girl reached with HPV vaccine are higher than the other two vaccines because of its delivery strategy.

Author: Ngabo F, Levin A, Wang SA, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Ngabo F, Levin A, Wang SA, et al. A Cost Comparison of Introducing and Delivering Pneumococcal, Rotavirus and Human Papillomavirus Vaccines in Rwanda. Vaccine. 2015;33(51):7357-7363.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV), Pneumococcus, Rotavirus

Topics: Introduction and service delivery, Immunization financing, Disease/vaccine specific information

Regions: Africa